1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends

Induced Pluripotent Stem Cells: Global Markets

  • June 2017
  • 139 pages
  • ID: 2212008

Summary

Table of Contents

• The global market for induced pluripotent stem cells (iPSCs) reached $2.1 billion in 2016. The market should reach $3.6 billion in 2021, increasing at a compound annual growth rate (CAGR) of 11.6% from 2016 through 2021.
• The U.S. market for iPSCs reached over $1.0 billion in 2016. The market should reach $1.8 billion in 2021, increasing at a CAGR of 11.3% from 2016 through 2021.
• Asia-Pacific market for iPSCs reached $449 million in 2016. The market should reach $854 million in 2021, increasing at a CAGR of 12.3% from 2016 through 2021.

Chapter 1: Introduction


Study Goals and Objectives
The aim of this report is to provide detailed market and industry analyses to help readers quantify and qualify the global market for induced pluripotent stem cells (iPSCs). Important trends in the field and market segments are identified, and market sizes and sales forecasts by segmented markets are provided through 2021. This report focuses on the market side rather than the technical side. The detailed market segmentation, market shares, major drivers, trend analysis and forecasts for the entire iPSCs market are analyzed.


Reasons for Doing This Study
Detailed market and industry analysis for the iPSCs market is needed. As a breakthrough technology recognized by the Nobel Prize in Physiology or Medicine 2012, iPSCs technology may bring a revolutionary change to modern medicine. Great opportunities always exist with high risks, but the detailed analysis and forecasts of the iPSC market can provide useful information for all management levels to help make strategic decisions in related areas. iPSC-related products are forming an emerging market despite the fact that iPSC clinical applications are still at their early stage. The potential scope of the iPSC market is becoming clear, and it is appropriate to review the emerging market, see the current size and share of each segment, evaluate the market trends and look to its future.


Intended Audience
This report is designed to satisfy the information needs of various individuals involved in the biological research, pharmaceutical and regenerative medicine marketplaces, including senior management corporate executives seeking to base their strategic decisions on the best available information on market forces and trends. It is also aimed at managers and executives in marketing, research, planning and sales departments who need readable, comprehensive and up-to-date background material on the marketplaces associated with the induced pluripotent stem cells with which they are operating. This report was prepared as a study of the global market for induced pluripotent stem cells. Information is presented with a specific focus on the various market segments, including those based on product type, product function, application, geography and technological method. The detailed segmentation is to provide a deep profile of the global iPSCs market, upon which the market forecasts are made.

This study will be of significant interest to academic institutions, hospitals, biotech and pharmaceutical companies, biopharmaceutical researchers, marketing executives from pharmaceutical and biotech companies, contract research organizations, biologists, chemists, physicians, pharmaceutical directors, product managers and representatives, and all manner of institutional directors from either public or private entities. It will also be of interest to investment bankers in the biotechnology and pharmaceutical sectors, insurance executives and life sciences product marketing managers.


Scope of Report
This study is focused on the market side of iPSCs rather than its technical side. Different market segments for this emerging market are covered. For example, application-based market segments include academic research, drug development and toxicity testing, and regenerative medicine; product function-based market segments include molecular and cellular engineering, cellular reprogramming, cell culture, cell differentiation and cell analysis; iPSC-derived cell-type-based market segments include cardiomyocytes, hepatocytes, neurons, endothelia cells and other cell types; geography-based market segments include the U.S., Europe, Asia-Pacific and Rest of World. Research and market trends are also analyzed by studying the funding, patent publications and research publications in the field.


Methodology
Both primary and secondary research methodologies were used to prepare this study. Primary research includes interviews with leading individuals in stem cell companies and industry associations. Primary sources of published data include company annual reports, SEC filings, and government and industry publications. Secondary sources consist of literature searches, industry journals and other commercial publications. Data for market estimates and forecasts are pooled from a range of sources that were critically assessed by BCC Research.


Information Sources
Information sources included marketing strategists, industry executives, academic experts, government agencies and regulatory bodies, and surveys of scientists in both academic and industrial areas. Company annual reports and Securities and Exchange Commission (SEC) filings, journal articles, newsletters, expert blogs and data from related institutions were also reviewed.


Geographic Breakdown
In this report, the geographic regions considered for market analysis include, and only include:
United States
• California
• Massachusetts
• New York
• Wisconsin
• Other States

Europe
Asia-Pacific
Rest of World

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Amrita helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Stem Cell Therapy for Diabetes and Related Conditions - A Pipeline Analysis Report

  • $ 3500
  • Industry report
  • October 2017
  • by Infiniti Research Limited

Stem cell therapy for diabetes and related conditions: An insightThe stem cell therapy for diabetes and related conditions pipeline analysis report includes ongoing clinical and non-clinical trends in ...

Stem Cell Banking Market: Forecast until 2021

  • $ 5650
  • Industry report
  • July 2017
  • by MarketsandMarkets

The global stem cell banking market is expected to reach USD 3.96 billion by 2021 from USD 1.58 billion in 2016, at a CAGR of 20.2% from 2016 to 2021. The storage services segment is expected to contribute ...

Clinical Research in Hematopoietic Stem Cell Transplantation in H2, 2017

  • $ 2500
  • Industry report
  • September 2017
  • by GlobalData

Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, 2017SummaryGlobalData’s clinical trial report, “Hematopoietic Stem Cell Transplantation Global Clinical Trials Review, H2, ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.